News

4:31 AMYahoo Finance

Hims & Hers Health faces expanded FTC lawsuit over privacy, Billing Practices

HIMS−5.2%

8:10 PMYahoo Finance

Hims & Hers (HIMS) stock price faces Q3 results margin reckoning

HIMS−5.2%

6:10 PMYahoo Finance

HIMS stock faces Dual Blow from expanded FTC privacy lawsuit after selloff driven by Q3 subscriber loss

HIMS−5.2%

2:20 PMYahoo Finance

HIMS Q3 earnings call highlights Marketing Reset and margin pressure

HIMS−5.2%

2:11 PMYahoo Finance

Why is Hims & Hers Health (HIMS) Bringing Andrew Huberman Onto its board?

HIMS−5.2%

12:03 PMYahoo Finance

Hims & Hers Health Inc (HIMS) (Q3 2026) earnings call highlights: Revenue surges 49% to ...

HIMS−5.2%

11:11 AMYahoo Finance

HIMS may see heightened ‘gyrations’ as weight-loss Drug Trends fuel subscriber Uncertainty, Jefferies warns – stock hits 7-month lows

HIMS−5.2%

10:45 AMYahoo Finance

Hims & Hers stock sinks after Q3 results, outlook disappoints

HIMS−5.2%

10:24 AMYahoo Finance

Hims & Hers cuts 2026 earnings outlook despite 49% revenue growth

HIMS−5.2%

6:16 AMYahoo Finance

Hims & Hers plans November launch of peptide treatments as higher costs weigh on profit outlook

HIMS−5.2%

5:44 AMInvesting.com

Why is Hims & Hers Health stock sliding today?

HIMS−5.2%

5:28 AMInvesting.com

Why is Hims & Hers Health stock sliding today?

HIMS−5.2%

12:14 AMYahoo Finance

What Hims & Hers Health (HIMS) said on its Q3 earnings call

HIMS−5.2%

5:00 PMYahoo Finance

Hims & Hers Health (HIMS) Q3 earnings: Taking a look at key Metrics Versus estimates

HIMS−5.2%

4:48 PMYahoo Finance

Hims & Hers shares dip as margin pressure and weak outlook hit sentiment

HIMS−5.2%

4:35 PMYahoo Finance

Hims & Hers Health, Inc. (HIMS) Q3 earnings and revenues miss estimates

HIMS−5.2%

4:34 PMYahoo Finance

Hims & Hers Health (NYSE:HIMS) posts Q3 2026 sales in line with estimates but full-year sales guidance misses expectations

HIMS−5.2%

4:05 PMYahoo Finance

Hims & Hers Health, Inc. Reports Third quarter 2026 financial results

HIMS−5.2%

4:05 PMYahoo Finance

Dr. Andrew Huberman joins Hims & Hers Board of Directors

HIMS−5.2%

3:16 PMYahoo Finance

Hims & Hers Health (HIMS) could be 85% undervalued following the Eli Lilly deal

HIMS−5.2%

12:11 PMYahoo Finance

Hims & Hers Health (HIMS) adds FDA approved obesity drugs to its platform

HIMS−5.2%

10:25 PMYahoo Finance

Hims & Hers Health vs. Intuitive Surgical: Which Healthcare stock is a better buy for 2027?

HIMS−5.2%ISRG−2.1%

4:11 PMYahoo Finance

Hims & Hers surges on 'surprising and Inevitable' deal with Eli Lilly

HIMS−5.2%

12:57 PMYahoo Finance

Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugs

HIMS−5.2%LLY−0.5%

11:28 AMYahoo Finance

Hims & Hers rises 5% as Eli Lilly deal brings $149 obesity pill access

HIMS−5.2%

10:14 AMYahoo Finance

HIMS' Q3 earnings: Can Weight loss momentum Drive Performance?

HIMS−5.2%

8:24 AMYahoo Finance

Why Hims & Hers Health stock was in Dire need of this Eli Lilly Agreement

HIMS−5.2%